ZILBRYSQ® For Treatment Of gMG
ONWARDTM For Patient Support
ZILBRYSQ® (zilucoplan) Injection For gMG Treatment
Description: This domain name has been activated for a Combell.com customer
domain name (207841) domains (84229) webhosting (47432) email (31123) coming soon (10773) parkpage (9294) ssl (7008) sitebuilder (5919) combell (5558)
Medication Guide |
Prescribing Information
A REMS is a strategy to manage known or potential risks associated with a drug and is required by the Food and Drug Administration (FDA) to ensure that the benefits of the drug outweigh its risks. ZILBRYSQ has a REMS because it increases your chance of getting a meningococcal infection. The infection can quickly become life threatening or fatal if not recognized and treated early. ZILBRYSQ is only available through a restricted distribution program called the ZILBRYSQ REMS.
ZILBRYSQ® For Treatment Of gMG
ONWARDTM For Patient Support
ZILBRYSQ® (zilucoplan) Injection For gMG Treatment